Researchers revealed a potentially promising strategy to treat brain cancer patients
Image Credit: shortpedia
Researchers have claimed that they have discovered a potentially promising strategy to treat isocitrate dehydrogenase brain tumours, which are the most common brain tumours diagnosed in younger adults aged 18 to 45 years. Researchers revealed that IDH mutant gliomas have a metabolic weakness making them especially susceptible to treatments that lower NAD+ levels, a ubiquitous and vital metabolic molecule.